Global Orthobiologics Market:
Market Outline: Global Orthobiologics Market
Orthobiologics are biological substances that are used to help injuries to heal more quickly. Orthobiologics are used to improve the healing of injured muscles, fractures, tendons, and ligaments. Orthobiologics are made from substances that occur naturally in the body. When they are used in more amounts, they may help to increase the healing process. When a tissue is injured bleeding occurs, after bleeding matrix, stem cells and growth factors play an important role in tissue healing and they are natural orthobiologics in human body. Matrix serves as building blocks that help to fill tissue gaps. Growth factors act on stem cells to cause the repair of the injured tissue.
Market Dynamics: Global Orthobiologics Market
Sports related injuries are common among professional and recreational athletes are increasingly encountered and diagnosed. They demand quick healing so that they can return to their normal sporting activities. Hence, orthobiologics is gaining more preference from various physicians. Bone grafts act by their osteoinductive, osteoconductive and osteogenic properties to stimulate new bone formation and have no effect on the healing of muscles, tendons and ligaments. On the other hand, autologous blood, PRP and autologous conditioned serum deliver growth factors to the diseased areas to stimulate the repair process. These biologic substances have their own advantages and some disadvantages also. Lack of clinical data and cost-intensive products are restrain the growth of the market.
Market Scope: Global Orthobiologics Market
Global orthobiologics market is segmented based on product type, application, and end user
Based on product type, market is segmented into the following:
- Viscosupplementation Products
- Synthetic Orthobiologics
- DBM (Demineralized Bone Matrix )
- BMP (Bone Morphogenetic Proteins)
- PRP (Platelet-Rich Plasma)
Based on the end user type, the market is segmented into the following:
- Research and Academic Institutes
- Dental Clinics and Facilities
Based on the application type, the market is segmented into the following:
- Maxillofacial and Dental Applications
- Osteoarthritis and Degenerative Arthritis
- Soft Tissue Injuries
- Spinal Fusion
- Fracture Recovery
Based on the type, the market is segmented into the following:
- Wrist and shoulder
Regional Analysis: Global Orthobiologics Market
Geographically, global Orthobiologics market is distributed into North America, Asia Pasiffic, Europe, Latin America, and Middle East & Africa. North America is expected to command the largest share of the market in 2017 due to an increase in incidence of spinal disorders, rising geriatric and obese population, growing preference for minimally invasive procedures, and growing physician and patient awareness about newly introduced treatment procedures and technologies. However, Asia Pacific is expected to register the highest growth rate during the forecast period. The presence of a large geriatric and target patient population, high incidence of osteoarthritis and obesity, increase in government spending on healthcare, and improving healthcare infrastructure are some of the major factors driving the growth of the Asia Pacific market.
On the other hand, the high cost associated with orthobiologics-based treatments is the major factor restraining the growth of the orthobiologics market.
Competition Assessment: Global Orthobiologics Market
Some of the players in the global orthobiologics market include:
- NuVasive Inc.,
- Stryker Corporation
- Zimmer Biomet
- Orthofix International
- RTI Surgical Inc.,
- Kuros Biosciences Ltd
- Bioventus LLC
- DePuy Synthes (Johnson and Johnson)
- SeaSpine Holdings Corporation
Notable Market Developments: Global Orthobiologics Market
In September 2018, NuVasive, Inc. launched a product line for Propel DBM. The Propel DBM product line includes gel, gel plus, and putty plus.